Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) just unveiled an update.
Shandong Xinhua Pharmaceutical Company Limited has announced a final cash dividend of RMB 0.25 per share for the financial year ending December 31, 2024. The announcement reflects the company’s financial performance and commitment to returning value to shareholders, although specific details regarding the payment date and withholding tax are yet to be disclosed.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Hong Kong Stock Exchange and engages in manufacturing a range of pharmaceutical goods.
YTD Price Performance: -0.69%
Average Trading Volume: 3,436,257
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$9.16B
Learn more about 0719 stock on TipRanks’ Stock Analysis page.